Cambridge, MA Associate​/Senior Associate, Molly Gibson’s Pioneering Busi

Associate/ Senior Associate, Molly Gibson’s Pioneering Business Unit (PBU)

Cambridge, MA USA

As an Associate or Senior Associate at Flagship Pioneering in Molly Gibson’s Pioneering Business Unit (PBU), you will ideate, research, and refine novel venture hypotheses, validate key underlying unknowns of biology or technology, and transition pressure‑tested ideas into building a New Co around the science. You will help drive every facet of company origination from the early stages, including identification and recruitment of critical partners and advisors, establishment of foundational IP, hiring and leadership of the early scientific team, and establishment of working norms and culture for the team.

In this role you will partner with stakeholders across the broader Flagship ecosystem to bring the full experience of Flagship to support your companies. A successful candidate will become the expert on the foundational science of the company, frame and clearly communicate the strategy, and translate that strategy into a plan and lead operationalization of that plan alongside a Principal or Partner on the venture creation team.

Flagship Pioneering (“FSP”) conceives and develops first‑in‑category bioplatform companies to transform human health and sustainability. FSP has developed over 100 scientific ventures, resulting in more than $130 billion in aggregate value. FSP seeks to change the world by addressing some of humanity’s most urgent challenges: curing intractable diseases, improving human health, and feeding the world by advancing the resiliency and sustainability of agriculture.

• Contribute to and lead Flagship model explorations to rapidly assess interesting areas of science and develop novel, actionable and high‑value venture hypotheses
• Outline key scientific questions to enable venture hypotheses and develop experimental plans to rapidly create value and pressure‑test ideas
• Identify, build, and maintain relationships with appropriate academic KOLs and thought experts, i.e., introducing them to the Flagship model, getting early buy‑in, vetting/validation and de‑risking key concepts of venture hypotheses
• Understand IP landscape, formulate initial strategy, and write seminal applications for the technology and company. Assess patentability of existing IP landscape, including that of key competitors and of potentially licensable estate
• Develop corporate strategy and operations plan for the company. Define value creation, identify application spaces, build out organizational chart, define company goals, timelines and resourcing, and identify strategic inflection points to set the company on the path to rapid growth and success
• Develop audience‑specific pitches for company
• Support business development activities and continue to evolve the story
• Manage and coordinate early scientific and IP employees. Source, recruit and manage KOLs and early‑stage employees as well as relationships with CROs.
• Manage & lead scientific team (internal or external) and daily research. Manage operational tasks, including establishing lab facilities, purchasing, HR, real estate acquisition, etc.
• Become institutional subject‑matter expert and transfer to active company team. Stay up to date on the literature, conferences, funding opportunities, and new developments.
• Work closely with and leverage Flagship operations teams (Finance, IP, IT, HR, and Talent) expertise for maximal operational excellence

The ideal candidate has a STEM‑based PhD or MD from a top university and 2 or more years of experience in life sciences biotech, start‑up or entrepreneurial activities. The candidate must have a passion for novel science and be operationally savvy.

• Proven ability to rapidly become conversant in new areas of science and capable of engaging thought leaders at the deepest level of technological understanding
• Ability to define a clear and compelling value proposition of a given scientific opportunity and effectively and cogently communicate that to technical and non‑technical audiences
• Basic understanding of multiple therapeutic modalities of drug discovery…